Gary B. Gordon, Director at TriSalus Life Sciences, Inc. (TLSI), bought 10,000 shares at $2.46 ($25K) on 2026-05-15, disclosed to the SEC on 2026-05-18.
Open-market purchase of $25k TLSI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| AYLA | SELL | 2021-01-22 | $45K | — | Filing → |